Metaphore Biotechnologies

About:

Metaphore Biotechnologies is a firm that uses biomimicry and machine learning to unlock the revolutionary therapeutic.

Website: https://metaphorebio.com

Twitter/X: MetaphoreBio

Top Investors: Flagship Pioneering

Description:

Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential of functional molecular mimics. The MIMiCTM platform, developed by the business, is a computationally driven bio platform for developing novel therapies in which function, specificity, and selectivity may be optimized. Metaphore is dedicated to uncovering previously inaccessible pharmacological targets and achieving breakthroughs that exceed today's medications for maximum patient effect.

Total Funding Amount:

$50M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)metaphorebio.com.

Founders:

Lovisa Afzelius

Number of Employees:

11-50

Last Funding Date:

2023-05-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai